AEMD insider receives 42,000 shares in stock awards
By AlphaYouPublished Form 4
FRAKES JAMES B
Reporting filer
FRAKES JAMES B reported 42,000 shares of Common Stock in AETHLON MEDICAL INC as grants or awards dated 2026-10-08. The Form 4 was disclosed on Oct 14, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Oct 14, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | FRAKES JAMES B | 2026-10-08 | A | Grant or award | 42000 | 0.00 | 42,063 | 6 days | Filed terms
|
Common Stock
- Owner
- FRAKES JAMES B
- Date
- 2026-10-08
- Code
- A
- Action
- Grant or award
- Quantity
- 42000
- Price
- 0.00
- Following holdings
- 42,063
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-08
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 42000
- id: F1
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 42063
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- FRAKES JAMES B: CFO/CEO, Director.
- F1: Represents a grant of 42,000 restricted stock units ("RSUs") pursuant to the Issuer's 2020 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest over the one-year period following October 8, 2026, subject to the Reporting Person's continued service through the applicable vesting dates. Notwithstanding the foregoing, the RSUs will become fully vested upon the closing of the Issuer's proposed merger with North Immunology, Inc.
Original sources
Prepared automatically from public filing data. Report a correction.